Parties d'ouvrages collectifs (13)
  1. 1. Taghavi, M., Jabrane, A., Jacobs, L., Mesquita, M., Demulder, A., & Nortier, J. (2024). Antiphospholipid Mediated Arteriovenous Fistula Complications. In MDPI Encyclopedia.
  2. 2. Nortier, J., Vanherweghem, J.-L., & Jelaković, B. (2022). Aristolochic acid Nephropathy and Balkan Nephropathy. In M. G. Atta & M. A. Perazella (Eds.), Tubulointerstitial Nephritis. Springer. doi:10.1007/978-3-030-93438-5
  3. 3. Nortier, J., & Vanherweghem, J.-L. (2021). Chinese herbs (Aristolochic acid nephropathy) and other rare causes of interstitial nephropathy. In J. Barratt, P. Topham, S. Carr, M. Arici, & A. Liew (Eds.), The Oxford Desk Reference Nephrology (2 ed., pp. 183-184). Oxford: Oxford University Press. doi:10.1093/med/9780198777182.001.0001
  4. 4. Bunel, V., Antoine, M.-H., & Nortier, J. (2021). Drug-induced nephropathies. In J. Barratt, P. Topham, S. Carr, M. Arici, & A. Liew (Eds.), The Oxford Desk Reference Nephrology (2 ed., pp. 200-212). Oxford: Oxford University Press. doi:10.1093/med/9780198777182.001.0001
  5. 5. Baudoux, T., & Nortier, J. (2017). Nephrotoxicity of herbal products. In Toxicology of Herbal Products (pp. 307-344). Springer International Publishing. doi:10.1007/978-3-319-43806-1_13
  6. 6. Bunel, V., Souard, F., Antoine, M.-H., Stévigny, C., & Nortier, J. (2017). Nephrotoxicity of Natural Products: Aristolochic Acid and Fungal Toxins. In Reference Module in Biomedical Sciences. Elsevier. doi:10.1016/B978-0-12-801238-3.64093-X
  7. 7. Nortier, J., Debelle, F., & Vanherweghem, J.-L. (2009). Drug-induced nephropathies. In J. Barratt, K. Harris, & P. Topham (Eds.), The Oxford Desk Reference Nephrology (pp. 698-706). Oxford University Press.
  8. 8. Nortier, J., & Vanherweghem, J.-L. (2009). Chinese herbs (Aristolochic acid nephropathy) and other rare causes of interstitial nephropathy. In J. Barratt, K. Harris, & P. Topham (Eds.), The Oxford Desk Reference Nephrology (pp. 240-241). Oxford University Press.
  9. 9. Debelle, F., Vanherweghem, J.-L., & Nortier, J. (2009). Néphropathie aux acides aristolochiques: de l’observation clinique au modèle expérimental. In J. Hamburger, P. Lesavre, T. Drüecke, C. Legendre, & P. Niaudet (Eds.), Actualités Néphrologiques (pp. 188-200).(Flammarion Médecines Sciences).
  10. 10. Nortier, J., Zlotta, A., Petein, M., Depierreux, M., Muniz Martinez, M. C., & Vanherweghem, J.-L. (2007). Upper urinary tract carcinoma after intake of Aristolochia fangchi: value of urinary cytology in end-stage « Chinese-herb nephropathy ». In L. P. Jeffries (Ed.), Trends in Cancer Research (pp. 219-229). Nova Science Publishers.
  11. 11. Nortier, J., Zlotta, A., Petein, M., Depierreux, M., Muniz Martinez, M. C., & Vanherweghem, J.-L. (2006). Upper urinary tract carcinoma after intake of aristolochia fangchi: Value of urinary cytology in end-stage "Chinese-herb nephropathy". In K. R. Nuñez (Ed.), Trends in Kidney Cancer Research (pp. 77-87). New York: Nova Science Publishers, Inc.(Horizons in Cancer Research, 18).
  12. 12. Vanherweghem, J.-L., Debelle, F., Muniz Martinez, M. C., & Nortier, J. (2003). Chronic interstitial renal fibrosis, Fanconi syndrome and urinary tract carcinomas secondary to herbal remedies containing aristolochic acids (Chinese-herb nephropathy –Aristolochia nephropathy). In M. De Broe (Ed.), Clinical Nephrotoxins (pp. 579-586). Kluwer Academic Publisher.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>